UroLift® System FAQs

UroLift®, a minimally-invasive, breakthrough treatment, generally takes less than an hour and offers multiple benefits for patients with prostate enlargement.

With the Urolift® System, patients usually go home the same day. They experience minimal downtime, without a catheter and many patients experience symptom relief as early as 2 weeks after the procedure.

The UroLift® System is a safe and effective treatment for patients with BPH symptoms; better than most traditional surgical options. Patients reported relief better than with medications in a risk profile. 1

In a largely significant study on the UroLift® System, there were no newly reported instances of erectile dysfunction or ejaculatory dysfunction.4 Studies show that other BPH therapies such as TURP, laser, and even medication did not always produce such positive results.

Yes! UroLift® is covered by Medicare and also by many private insurance companies. You should contact your insurance provider for specific coverage information regarding this treatment.

Urethral implants, a key factor of what makes the UroLift® System effective, are intended to be permanent. If needed, your doctor can remove your implant (which is made from standard surgical implantable materials) by cutting the suture and retrieving the urethral end piece with a standard grasper. The capsular tab will remain in place inside the body.

The most common side effects reported by patients in clinical studies were mild to moderate. They included pain or burning with urination, blood in the urine, pelvic pain, urgency with urination, and/or the inability to control the urge to urinate. Most of these symptoms resolved themselves within two to four weeks after the procedure.1